Clinical Trial Update: Clinical Trial Nuedexta in Subjects With ALS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for Nuedexta in individuals with amyotrophic lateral sclerosis were posted in March 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• NUEDEXTA (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)

Snippet

Sponsor: Center for Neurologic Study, La Jolla, California, | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: COMPLETED | Results posted: 2017-03-24